Cargando…
Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study
BACKGROUND: Previous randomized controlled trials demonstrated a protective effect of renin angiotensin system blocking agents for the development of type-2 diabetes in patients with pre-diabetes. However, there are no real-world data available to illustrate the relevance for clinical practice. METH...
Autores principales: | Zidek, Walter, Schrader, Joachim, Lüders, Stephan, Matthaei, Stephan, Hasslacher, Christoph, Hoyer, Joachim, Zemmrich, Claudia, Bramlage, Peter, Sturm, Claus-Dieter, Paar, W Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313888/ https://www.ncbi.nlm.nih.gov/pubmed/22230104 http://dx.doi.org/10.1186/1475-2840-11-1 |
Ejemplares similares
-
First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation
por: Zidek, Walter, et al.
Publicado: (2008) -
Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
por: Bönner, G, et al.
Publicado: (2013) -
Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers – drug classes with low adherence in antihypertensive therapy
por: Ritscher, Sabrina, et al.
Publicado: (2019) -
Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
por: Simonyi, Gábor, et al.
Publicado: (2016) -
Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study
por: Boger-Megiddo, Inbal, et al.
Publicado: (2010)